GO:0015917 aminophospholipid transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015917 aminophospholipid transport describes the directed movement of aminophospholipids such as phosphatidylserine (PS) and phosphatidylethanolamine (PE) into, out of, or within a cell, or between cells, by means of a transporter or pore.
• The process is best known for establishing and maintaining the asymmetric distribution of phospholipids across the plasma membrane, with PS and PE concentrated on the cytoplasmic leaflet.
• P4-ATPases (flippases) are the principal transporters that move aminophospholipids from the exoplasmic to the cytoplasmic leaflet, and they typically require a CDC50 family chaperone subunit for function.
• Loss of aminophospholipid asymmetry, particularly PS exposure on the outer leaflet, is a signal for apoptosis, blood coagulation, and cell fusion.
• Defects in aminophospholipid transport are linked to liver disease, neurological disorders, and parasitic infections, making the pathway a target for experimental modeling.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models are essential tools for dissecting the causal roles of flippases and their partners in aminophospholipid transport.
Description
Aminophospholipid transport (GO:0015917) is the directed movement of aminophospholipids into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. Aminophospholipids are phospholipids that contain phosphoric acid as a mono- or diester and an amino (NH2) group, with phosphatidylserine (PS) and phosphatidylethanolamine (PE) being the most studied members. This process is fundamental to membrane biology because it establishes the asymmetric distribution of lipids across the bilayer, a hallmark of eukaryotic cells. Researchers study aminophospholipid transport to understand how cells maintain membrane integrity, how they signal during apoptosis, and how defects in these pathways contribute to disease. The identification and purification of aminophospholipid flippases provided the first biochemical evidence for the transporters responsible for this movement. Subsequent work revealed that P4-ATPases, a subfamily of P-type ATPases, are the key enzymes that catalyze the inward translocation of aminophospholipids, often in complex with CDC50 proteins. Because aminophospholipid transport is implicated in cell fusion, blood coagulation, and host-pathogen interactions, it has become a focus for both basic and translational research.
aminophospholipid transport At A Glance
| GO ID | GO:0015917 |
|---|---|
| GO term | aminophospholipid transport |
| Ontology | biological_process |
| Synonym | None |
| Definition | The directed movement of aminophospholipids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Aminophospholipids contain phosphoric acid as a mono- or diester and an amino (NH2) group. |
| Major function | Maintains membrane lipid asymmetry by translocating phosphatidylserine and phosphatidylethanolamine across bilayers. |
| Key transporters | P4-ATPases (flippases) such as ATP8A1, ATP8A2, ATP8B1, ATP11A, ATP11C, often with CDC50A (TMEM30A) or CDC50B (TMEM30B) subunits. |
| Cellular context | Plasma membrane, secretory pathway, and other organelle membranes. |
| Related processes | Apoptosis, cell fusion, blood coagulation, and membrane trafficking. |
What Is GO:0015917?
In simple terms, aminophospholipid transport is the process by which cells move certain fat-like molecules that contain an amino group, such as phosphatidylserine and phosphatidylethanolamine, from one side of a membrane to the other or between compartments. The Gene Ontology defines it as the directed movement of aminophospholipids into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. Aminophospholipids contain phosphoric acid as a mono- or diester and an amino (NH2) group. This process is essential for maintaining the asymmetric distribution of lipids in biological membranes, where aminophospholipids are normally enriched on the cytoplasmic leaflet.
Why Is aminophospholipid transport Important in Cell Biology?
Aminophospholipid transport is critically important because it controls the asymmetric distribution of PS and PE across cell membranes, a feature that is essential for normal cell physiology and serves as a signaling platform for numerous biological events. When this asymmetry is lost, PS becomes exposed on the cell surface, triggering recognition by phagocytes, activation of the coagulation cascade, and cell fusion processes. Moreover, defects in the transporters that mediate aminophospholipid transport are associated with human diseases, including progressive familial intrahepatic cholestasis and neurological disorders. Understanding this process therefore provides insight into fundamental membrane biology and offers potential therapeutic targets for a range of conditions.
• Maintains the asymmetric distribution of phosphatidylserine and phosphatidylethanolamine, which is essential for membrane integrity and function.
• Controls exposure of phosphatidylserine on the outer leaflet, a key signal for apoptosis and phagocytic clearance.
• Regulates cell fusion events, including myoblast fusion during muscle development.
• Influences blood coagulation by regulating phosphatidylserine-dependent activation of clotting factors.
• Is required for normal liver function, as defects in aminophospholipid transporters cause cholestatic liver disease.
• Plays a role in host-pathogen interactions, as parasites like Leishmania and Trypanosoma rely on P-type ATPases for membrane lipid transport.
• Provides a mechanism for membrane remodeling during vesicular trafficking and organelle biogenesis.
• Serves as a target for drug development against parasitic infections and for modulating cell death pathways.
• Helps explain the molecular basis of diseases linked to flippase mutations, such as ATP8B1-related cholestasis.
• Offers a model system to study the broader family of P4-ATPases and their substrate specificity.
What Happens During aminophospholipid transport?
Substrate recognition and binding
In simple terms: The transporter first grabs the specific lipid molecule it needs to move.
Aminophospholipid transport begins when a transporter, typically a P4-ATPase, recognizes and binds its substrate, such as phosphatidylserine or phosphatidylethanolamine, on one side of the membrane. This binding is highly specific, as P4-ATPases can discriminate between different phospholipid headgroups, although some can transport other lipids as well. The interaction occurs within the transmembrane domain of the transporter, where the lipid is positioned for translocation.
Translocation across the lipid bilayer
In simple terms: The transporter flips the lipid from one side of the membrane to the other.
Once bound, the aminophospholipid is moved across the lipid bilayer, typically from the exoplasmic (outer) leaflet to the cytoplasmic (inner) leaflet. This flippase activity is energy-dependent and requires ATP hydrolysis by the P4-ATPase. The movement establishes and maintains the asymmetric distribution of aminophospholipids, which is critical for membrane function.
Role of CDC50 chaperone subunits
In simple terms: A helper protein called CDC50 is needed for the transporter to work properly.
Many P4-ATPases require an associated subunit from the CDC50 family (such as CDC50A/TMEM30A) for their exit from the endoplasmic reticulum and for full transport activity. CDC50A is required for aminophospholipid transport and cell fusion in mouse C2C12 myoblasts, demonstrating its essential role in this process. Without the chaperone, the flippase may be unstable or mislocalized, leading to defective lipid transport.
Regulation of membrane asymmetry and downstream signaling
In simple terms: The flipping process controls which lipids are on the outside, which affects how cells behave.
The continuous activity of aminophospholipid transporters maintains the asymmetric distribution of PS and PE, keeping them predominantly on the cytoplasmic leaflet. When this asymmetry is disrupted, for example during apoptosis, PS becomes exposed on the cell surface and serves as a signal for phagocytosis and blood coagulation. Thus, aminophospholipid transport is not only a housekeeping function but also a regulatory node for cell death and intercellular communication.
Key Genes Involved in GO:0015917 aminophospholipid transport
The following genes encode proteins that directly mediate or regulate aminophospholipid transport, including P4-ATPases and their accessory subunits.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATP8A1 | P4-ATPase flippase that transports aminophospholipids | Studied for its role in membrane asymmetry and vesicle trafficking. |
| ATP8A2 | P4-ATPase flippase, highly expressed in neurons | Linked to neurological disorders; used to study lipid transport in the brain. |
| ATP8B1 | P4-ATPase flippase, important in liver | Mutations cause progressive familial intrahepatic cholestasis; model for liver disease. |
| ATP8B2 | P4-ATPase flippase | Investigated for its role in membrane lipid organization. |
| ATP8B3 | P4-ATPase flippase | Studied in the context of sperm function and membrane dynamics. |
| ATP8B4 | P4-ATPase flippase | Associated with immune and neurological functions. |
| ATP9A | P4-ATPase flippase | Implicated in endosomal trafficking and membrane remodeling. |
| ATP9B | P4-ATPase flippase | Studied for its role in the secretory pathway. |
| ATP10A | P4-ATPase flippase | Linked to metabolic and neurological traits. |
| ATP10B | P4-ATPase flippase | Investigated for its role in Parkinson's disease. |
| ATP10D | P4-ATPase flippase | Studied for its role in lipid metabolism. |
| ATP11A | P4-ATPase flippase | Regulates phosphatidylserine exposure and apoptosis. |
| ATP11B | P4-ATPase flippase | Involved in membrane trafficking and cell signaling. |
| ATP11C | P4-ATPase flippase | Important for B cell development and lipid asymmetry. |
| CDC50A (TMEM30A) | Chaperone subunit for P4-ATPases | Required for aminophospholipid transport and cell fusion. |
| CDC50B (TMEM30B) | Chaperone subunit for P4-ATPases | Assists in flippase maturation and function. |
| CDC50C (TMEM30C) | Chaperone subunit for P4-ATPases | Testis-specific, involved in sperm lipid transport. |
| Drs2 | P4-ATPase flippase in yeast | Model for studying aminophospholipid transport mechanisms. |
How Is aminophospholipid transport Regulated?
Aminophospholipid transport is regulated at multiple levels. The expression and activity of P4-ATPases can be controlled by transcriptional mechanisms, and their localization and stability depend on interaction with CDC50 family chaperones. Additionally, the transport process is influenced by the lipid composition of the membrane and by post-translational modifications. In the context of apoptosis, the activation of scramblases and the inactivation of flippases lead to phosphatidylserine exposure, indicating that aminophospholipid transport is dynamically regulated during cell death. Furthermore, in parasites such as Leishmania and Trypanosoma, P-type ATPases involved in aminophospholipid transport are regulated in a stage-specific manner, reflecting their importance in the life cycle.
aminophospholipid transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ATP8B1 | Progressive familial intrahepatic cholestasis | Knockout or point-mutation knock-in in liver cell lines or mouse models. |
| ATP8A2 | Neurological disorders (e.g., cerebellar ataxia) | Knockout or overexpression in neuronal cell lines. |
| ATP10B | Parkinson's disease | Knockout or point mutation in dopaminergic neurons. |
| CDC50A (TMEM30A) | Defective cell fusion and lipid asymmetry | Knockout in C2C12 myoblasts or other fusion-competent cells. |
| ATP11A | Apoptosis and cancer | Overexpression or knockout in cancer cell lines. |
Liver disease and cholestasis
Mutations in ATP8B1, a P4-ATPase that mediates aminophospholipid transport, cause progressive familial intrahepatic cholestasis, a severe liver disease characterized by impaired bile flow. Studies of hepatocanalicular transport defects have provided insights into the role of aminophospholipid flippases in maintaining the canalicular membrane and in the pathogenesis of cholestasis. Experimental models with ATP8B1 knockout or point mutations are used to study the molecular mechanisms of this disease.
Neurological disorders
Several P4-ATPases, such as ATP8A2 and ATP10B, are highly expressed in the nervous system, and defects in aminophospholipid transport have been linked to neurological disorders including cerebellar ataxia and Parkinson's disease. The precise mechanisms are still under investigation, but proper lipid asymmetry is thought to be essential for neuronal membrane function and synaptic vesicle cycling.
Parasitic infections
Leishmania and Trypanosoma parasites rely on P-type ATPases for aminophospholipid transport, which is critical for their survival and virulence. These transporters are potential drug targets, and research into their function may lead to new antiparasitic therapies.
Cancer and cell death
Loss of aminophospholipid asymmetry, particularly phosphatidylserine exposure, is a hallmark of apoptosis and can influence tumor progression and immune recognition. Modulating aminophospholipid transport may therefore have therapeutic potential in cancer and other diseases where cell death signaling is dysregulated.
From aminophospholipid transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ATP8B1 impair aminophospholipid transport? | ATP8B1 knockout cell line (e.g., HepG2). |
| How does a disease-associated point mutation affect flippase activity? | Point-mutation knock-in of ATP8B1 or ATP8A2 in cultured cells. |
| Where is CDC50A localized during cell fusion? | Tagged knock-in of CDC50A with fluorescent protein in C2C12 cells. |
| Does overexpression of ATP11A alter phosphatidylserine exposure? | Overexpression of ATP11A in HeLa or other cell lines. |
| What is the role of P4-ATPases in parasite survival? | Knockout or knockdown of P-type ATPases in Leishmania or Trypanosoma. |
| Can aminophospholipid transport be monitored in real time? | Live-cell imaging with fluorescent lipid analogs in wild-type and mutant cells. |
How to Study the aminophospholipid transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescent lipid analog uptake | Rate of aminophospholipid internalization | Assessing flippase activity in live cells. |
| Flow cytometry with annexin V | Phosphatidylserine exposure on the cell surface | Detecting apoptosis or loss of lipid asymmetry. |
| ATPase activity assay | ATP hydrolysis by P4-ATPases | Measuring transporter activity in membrane fractions. |
| CRISPR knockout screening | Phenotypic changes upon gene loss | Identifying genes required for aminophospholipid transport. |
| Live-cell imaging | Real-time lipid movement | Visualizing flippase dynamics. |
| Co-immunoprecipitation | Protein-protein interactions | Identifying CDC50-P4-ATPase complexes. |
| RNA-seq | Transcriptional changes | Evaluating expression of lipid transporters under different conditions. |
| Proteomics | Global protein abundance and modifications | Discovering novel regulators of aminophospholipid transport. |
Fluorescent lipid analogs and imaging
The transport of aminophospholipids can be directly visualized using fluorescently labeled lipid analogs, such as NBD-labeled phosphatidylserine, in combination with confocal microscopy or flow cytometry. This approach allows researchers to track the movement of lipids across the membrane in live cells and to assess the impact of genetic perturbations.
Biochemical flippase assays
Biochemical assays using purified membranes or reconstituted systems can measure flippase activity by monitoring the ATP-dependent translocation of radiolabeled or fluorescent aminophospholipids. These assays have been instrumental in identifying and characterizing aminophospholipid flippases.
Genetic knockout and knockdown
CRISPR-Cas9-mediated knockout or RNA interference can be used to deplete specific P4-ATPases or CDC50 subunits, followed by functional assays to measure changes in lipid asymmetry, cell fusion, or apoptosis. Such studies have demonstrated the requirement of CDC50A for aminophospholipid transport in myoblasts.
Proteomics and interactomics
Mass spectrometry-based proteomics can identify proteins associated with P4-ATPases and their chaperones, providing insights into the molecular machinery of aminophospholipid transport. Co-immunoprecipitation and proximity labeling are commonly used to study these interactions.
How CRISPR Can Be Used to Study GO:0015917 aminophospholipid transport
Knockout
CRISPR-Cas9 knockout of genes such as ATP8B1, ATP11A, or CDC50A allows researchers to study the loss-of-function consequences on aminophospholipid transport. For example, knockout of CDC50A in C2C12 myoblasts impaired aminophospholipid transport and cell fusion, demonstrating its essential role. Knockout models are valuable for identifying the specific contributions of individual flippases to membrane asymmetry and downstream processes.
Point Mutation
Introducing disease-associated point mutations into P4-ATPase genes using CRISPR base editing or homology-directed repair enables the study of how specific amino acid changes affect transporter function. This approach is particularly useful for modeling inherited disorders such as ATP8B1-related cholestasis, where missense mutations are common.
Knock-in
Knock-in of fluorescent tags or epitope tags into endogenous loci, such as tagging CDC50A or ATP8A1, allows for real-time tracking of protein localization and dynamics in live cells. Tagged knock-in models are also useful for proteomic studies to identify interacting partners.
Overexpression
Overexpression of wild-type or mutant P4-ATPases, such as ATP11A or ATP8A2, can be achieved by CRISPR activation or by lentiviral delivery. This approach helps to determine whether increased flippase activity is sufficient to alter lipid asymmetry, cell survival, or other phenotypes.
How EDITGENE Supports aminophospholipid transport Research
Researchers studying aminophospholipid transport-related genes often need to determine whether a candidate gene is causally involved in lipid asymmetry, cell fusion, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional studies of GO:0015917 and its associated pathways.
Contact EDITGENE today to design your custom CRISPR model for aminophospholipid transport research.
Frequently Asked Questions About aminophospholipid transport
What is aminophospholipid transport?
Aminophospholipid transport (GO:0015917) is the directed movement of aminophospholipids, such as phosphatidylserine and phosphatidylethanolamine, into, out of, or within a cell, or between cells, by means of a transporter or pore.
What genes are involved in aminophospholipid transport?
Key genes include P4-ATPases such as ATP8A1, ATP8A2, ATP8B1, ATP11A, and ATP11C, as well as their chaperone subunits CDC50A (TMEM30A), CDC50B, and CDC50C.
How does aminophospholipid transport maintain membrane asymmetry?
P4-ATPases flip aminophospholipids from the outer to the inner leaflet of the membrane, keeping phosphatidylserine and phosphatidylethanolamine enriched on the cytoplasmic side.
What is the role of CDC50A in aminophospholipid transport?
CDC50A is a chaperone subunit required for the proper folding, localization, and activity of many P4-ATPases; its loss impairs aminophospholipid transport and cell fusion.
Which diseases are linked to defects in aminophospholipid transport?
Defects are associated with progressive familial intrahepatic cholestasis, neurological disorders, and parasitic infections.
How can I study aminophospholipid transport in the lab?
Common methods include fluorescent lipid analog uptake, flow cytometry with annexin V, ATPase activity assays, and CRISPR-based genetic screens.
What are P4-ATPases?
P4-ATPases are a subfamily of P-type ATPases that function as lipid flippases, translocating aminophospholipids across membranes using ATP energy.
Why is phosphatidylserine exposure important?
Phosphatidylserine exposure on the outer leaflet is a signal for apoptosis, blood coagulation, and phagocytic recognition.
Can CRISPR be used to model aminophospholipid transport diseases?
Yes, CRISPR knockout, point mutation knock-in, and overexpression models are widely used to study the functional consequences of mutations in flippase genes.
What is the connection between aminophospholipid transport and cell fusion?
Aminophospholipid transport, particularly by CDC50A-dependent flippases, is required for cell fusion events such as myoblast fusion during muscle development.
Conclusion
Aminophospholipid transport (GO:0015917) is a fundamental biological process that maintains membrane lipid asymmetry and regulates critical cellular events including apoptosis, cell fusion, and blood coagulation. The P4-ATPase flippases and their CDC50 chaperones are the central molecular players, and their dysfunction is linked to liver disease, neurological disorders, and parasitic infections. Continued research using advanced CRISPR models and biochemical assays will further illuminate the mechanisms and therapeutic potential of this pathway.
References
- 1. Grifell-Junyent M et al.. 2022. CDC50A is required for aminophospholipid transport and cell fusion in mouse C2C12 myoblasts.. J Cell Sci 135(5) PMID: 34664668
- 2. Devaux PF. 1988. Phospholipid flippases.. FEBS Lett 234(1):8-12 PMID: 3292284
- 3. Daleke DL et al.. 2000. Identification and purification of aminophospholipid flippases.. Biochim Biophys Acta 1486(1):108-27 PMID: 10856717
- 4. Meade JC. 2019. P-type transport ATPases in Leishmania and Trypanosoma.. Parasite 26:69 PMID: 31782726
- 5. Balasubramanian K et al.. 2003. Aminophospholipid asymmetry: A matter of life and death.. Annu Rev Physiol 65:701-34 PMID: 12471163
- 6. Thompson R et al.. 2000. Genetic defects in hepatocanalicular transport.. Semin Liver Dis 20(3):365-72 PMID: 11076402
- 7. Lopez-Marques RL et al.. 2014. P4-ATPases: lipid flippases in cell membranes.. Pflugers Arch 466(7):1227-40 PMID: 24077738
- 8. Shin HW et al.. 2019. Substrates of P4-ATPases: beyond aminophospholipids (phosphatidylserine and phosphatidylethanolamine).. FASEB J 33(3):3087-3096 PMID: 30509129
